Search results
Results from the WOW.Com Content Network
[2] [5] As public awareness of ADHD has increased, epidemiological studies have found a prevalence rate of 4–12% in children of ages 6–12 throughout the United States. Not only is ADHD the most commonly encountered childhood-onset disorder in neurodevelopment, there is also a high comorbidity rate linking ADHD with other behavioral ...
The Swanson, Nolan and Pelham Teacher and Parent Rating Scale (SNAP), developed by James Swanson, Edith Nolan and William Pelham, is a 90-question self-report inventory designed to measure attention deficit hyperactivity disorder (ADHD) and oppositional defiant disorder (ODD) symptoms in children and young adults.
Attention deficit/ hyperactivity disorder (ADHD) is one of the most prevalent neurological disorders found in children. [3]The ADHD-RS was created by George J. DuPaul, Thomas J. Power, Arthur D. Anastopoulos, and Robert Reid to address the need for an effective evaluation for children and adolescents suspected of having ADHD. [3]
The Wender Utah Rating Scale (WURS) is a psychological assessment tool used to help diagnose attention deficit hyperactivity disorder (ADHD) in adults. It is a self-report questionnaire that asks individuals to retrospectively recall and rate the frequency and severity of symptoms they experienced during childhood that are characteristic of ADHD.
Conversely, ADHD may more adversely affect productivity which represents the amount of work done in a particular time interval. Children with CDS seem to have more difficulty with consistently remembering things that were previously learned and make more mistakes on memory retrieval tests than do children with ADHD.
The AOL.com video experience serves up the best video content from AOL and around the web, curating informative and entertaining snackable videos.
Attention deficit hyperactivity disorder management options are evidence-based practices with established treatment efficacy for ADHD.Approaches that have been evaluated in the management of ADHD symptoms include FDA-approved pharmacologic treatment and other pharmaceutical agents, psychological or behavioral approaches, combined pharmacological and behavioral approaches, cognitive training ...
The KSADS-P was the first version of the K-SADS, developed by Chambers and Puig-Antich in 1978 as a version of the Schedule for Affective Disorders and Schizophrenia adapted for use with children and adolescents 6–19 years old. This version rephrased the SADS to make the wording of the questionnaire pertain to a younger age group. [1]